1.Research advance in noninvasive prenatal testing based on cell-free fetal DNA
Chinese Journal of Laboratory Medicine 2016;39(4):307-310
The discovery of cell-free fetal DNA ( cffDNA) in maternal plasma provides a new idea for noninvasive prenatal testing( NIPT).Though some studies to date have shown several fetal DNA markers, how to accurately distinguish cffDNA from the pool of maternal plasma free DNA is still a challenge.So far, NIPT based on cffDNA has been used for detection and study of a variety of diseases, along with the advance and development of technology, it will have a more broad application prospects.This article will make a review for the research status from the biological characteristics and the markers of cffDNA, the clinical applications and the existing issues and development prospects of NIPT based on cffDNA.
2.Design and implementation of temperature control system of high fever
Yongshou ZHANG ; Xiaochen ZHAO
China Medical Equipment 2013;(11):35-36
Objective: To cool down the implementation of field training injury cold and heat function of electric control part. Methods:To design of peripheral control circuit, the use of STM32 microcontroller software compiled program, temperature control function of the whole device. Results: Though the program running, it realized the function of temperature control device. Conclusion:STM32 MCU has powerful functions, low price, simple use, convenient development advantages, suitable for use in other medical equipment electrical control part.
3.The design and implementation of medical image processing system
Caiyun ZHAO ; Yongshou ZHANG ; Xiaochen ZHAO
China Medical Equipment 2014;(2):45-46,47
Objective:Based on the matrix laboratory (MATLAB) design and implementation of the digital image processing system, to achieve the goal of medical image information. Methods: To use MATLAB software to develop a design and implementation of the medical digital image processing system. Results:This paper presents a kind of digital image processing system based on MATLAB, including all aspects of the image processing. Conclusion:Through the research of medical image processing system, medical imaging for important information can be obtained.
4.Effect of Functional Electrical Stimulation on Postoperative Treatment of Lumbar Disc Herniation
Wenjuan WANG ; Xiaochen ZHAO ; Wei WANG
Journal of China Medical University 2015;(12):1087-1089
Objective to investigate the efficacy of functional electrical stimulation(FES)on the postoperative treatment of lumbar disc hernia-tion. Methods Informed consents were obtained from all the subjects before the study. totally 60 patients who had remnant nervous lesion after sur-gery of lumbar disc herniation were divided into two groups:FES group and Control group. FES group received treatment since the first day after sur-gery. the parameters of therapeutic apparatus were as follows:35 Hz,0.28 ms,1 time daily and 30 min each time. the intensity of the treatment was the maximum tolerated that the patients can take. the course was 4 weeks. the control group during the study did not receive any stimulation. the myodynamia of hallux dorsiflexion and JOA score of patients were recorded and analyzed. Results After 2 weeks treatment,the myodynamia of FES group was 15.10±5.03,which was significantly larger than that of the control group at 12.03±6.30(P < 0.05). After 4 weeks treatment,the myody-namia of FES group was 20.43±5.73,which was significantly larger than that of the control group at 14.57±7.17(P < 0.05). After 4 weeks of treat-ment,the JOA score of FES group was 24.63±1.91,which was significantly higher than that of the control group at 19.87±2.33(P < 0.05). Conclu-sion After 2-4 weeks of functional electrical stimulation therapy,myodynamia of hallux dorsiflexion in FES group was significantly improved. And at the 4th week after operation,JOA score was more higher than that of the control group. Functional electrical stimulation in the treatment of remnant nervous lesion after postoperative of lumbar disc herniation has exact curative effect,which is worthy of popularization.
5.Effects of mesalamine on the expression of TNF-α, IL-6, IL-17 and intestinal barrier function with ulcerative colitis
Xiaochen ZHANG ; Yan BAI ; Guogang ZHAO
Chinese Journal of Biochemical Pharmaceutics 2017;37(1):182-184,187
Objective To investigate the effect of mesalazine on the expression of TNF-α, IL-6, IL-17 and intestinal barrier function in patients with ulcerative colitis. Methods 76 patients with UC from January 2015 to April 2016 in The Fifth Central Hospital of Tianjin were collected and randomly divided into control group and observation group with 38 cases in each group. After admission were given maintenance of water and electrolyte, basic acid-base balance and nutritional support treatment, and the control group were treated with conventional drug sulfasalazine (SASP) treatment, two tablets each time, four times once day, four weeks for each course, the observation group was treated with mesalazine, four tablets each time, three times once day, four weeks each course of treatment. The levels of TNF-α, IL-6, IL-17, L/M and Baron endoscopic scores in the two groups were observed after two courses of treatment. The efficacy and side effects of the two groups were compared. Results No dropout or dropout cases in this study, two groups after the treatment of TNF-α, IL-6, IL-17, L/M, Baron scores were significantly decreased (P<0.05), but the observation group after treatment the above indexes were all significantly lower than the control group (P<0.05), the total effective rate of the observation group was 89.47%(34/38) higher than that of the control group 71.05%(21/38), the adverse reaction rate of 13.16% (5/38) was lower than that in the control group 34.21% (13/38), the differences were statistically significant(P<0.05). Conclusion Compared with conventional drug SASP, the effect of on the expression of TNF-α, IL-6 and IL-17 in serum of patients with UC and the improvement of intestinal barrier function can be effectively suppressed, which has the advantages of clinical efficacy and low adverse reaction rate.
6.Celecoxib suppresses xenograft tumor of colon cancer in nude mice
Shipeng ZHAO ; Fa ZHAO ; Mingyue XU ; Xiaochen ZHANG ; Jianhui CAI
Journal of Third Military Medical University 2003;0(14):-
Objective To evaluate the effects of celecoxib on tumor growth,COX-2 and survivin expressions and angiogenesis in nude mice. Methods Xenograft animal model was established by injecting human colon cancer HT-29 cells into the BALB/c nude mice subcutaneously. Fifty mice were randomly divided into 4 groups 16 d after injection:control group,celecoxib group(receiving 25,50,75,100 mg?kg-1?d-1 for 35 d). Tumor volumes were measured every week. The expression level of COX-2,survivin and the microvessel density (MVD) of the xenograft tumor tissues were measured by immunohistochemistry,and mRNA level of VEGF by RT-PCR. Results Celecoxib at dose of 25,50,75 and 100 mg?kg-1?d-1 inhibited the tumor volume by 34.94%,39.20%,53.50%,59.20% respectively,and showed more effective in suppressing the tumor growth than the control group(P
7.Microbial community in the Anammox process of thermal denitration tail liquid.
Jin LI ; Deshuang YU ; Dan ZHAO ; Xiaochen WANG
Chinese Journal of Biotechnology 2014;30(12):1865-1875
An anaerobic sequencing batch reactor (ASBR) was used to treat thermal denitration tail liquid and microbial community was studied. Activated sludge was taken from the reactor for scanning electron microscope analysis. The images showed that the dominant cells in the flora were oval cocci. Its diameter was about 0.7 μm. Through a series of molecular biology methods such as extracting total DNA from the sludge, PCR amplification, positive clone authentication and sequencing, we obtained the 16S rDNA sequences of the flora. Phylogenetic tree and clone library were established. The universal bacteria primers of 27F-1492R PCR amplification system obtained 85 clones and could be divided into 21 OTUS. The proportions were as follows: Proteobacteria 61.18%; Acidobacteria 17.65%; Chlorobi 8.24%; Chlorofexi 5.88%; Gemmatimonadetes 3.53%; Nitrospirae 2.35% and Planctomycetes 1.18%. The specific anammox bacterial primers of pla46rc-630r and AMX368-AMX820 PCR amplification system obtained 45 clones. They were divided into 3 OTUS. Candidatus brocadia sp. occupied 95.6% and unknown strains occupied 4.4%.
Ammonia
;
chemistry
;
Bacteria
;
Phylogeny
;
Polymerase Chain Reaction
;
RNA, Ribosomal, 16S
;
Sewage
;
microbiology
8.Thermo-chemotherapy effect of magnetic fluids combining with paclitaxel on human cervical cancer cells
Na XU ; Xiaochen DAI ; Lingyuen ZHAO ; Jintian TANG
Journal of International Oncology 2009;36(9):716-720
Objective To study the preparation method of magnetic fluids and its antitumor effect in combination with paclitaxel thermo-chemotherapy in vitro. Methods Magnetic fluids were prepared by copre-cipitation and modified by sodium oleate. Transmission electron microscopy, Fourier infrared spectroscopy and other instruments were used to characterize the products. The heat effect was studied under ahemating magnetic field in vitro. MTT assay was performed to examine the effect of magnetic fluids in combination with pachtaxel thermo-chemotherapy of human cervical cancer cells Caski. Results The prepared magnetic fluids were global with a diameter of 20~30 nm,Zeta potential was -11 mVto -16 mV. They had distinct heat effect in a alterna-ting magnetic field and could rise to a temperature for tumor thermo-chemotherapy (41 ~ 46℃). Thermo-ehem-otherapy could significantly inhibit the proliferation and promote of the Caski cells, which were more distinct than the magnetic fluids hyperthermia and paclitaxel chemotherapy. Conclusion Magnetic fluids in combina-tion with paclitaxel thermo-chemotherapy has advantages of chemotherapy and hyperthermia. This treatment shows better effects on cell experiments than that of using paclitaxel chemotherapy alone and may provide a new way in clinical treatment for human cervical cancer.
10.The research on expression and clinical significance of MCM2 in BTCC
Aili ZHANG ; Shubing HE ; Zhihong ZHAO ; Xiaochen NI
China Oncology 2001;0(03):-
Background and purpose:It is verifi ed that MCM2 is a specifi c marker in the cell cycle,and expressed in all cells entering into the cycle,however,no expression is found in the differentiated cells and static period cell.Therefore,in the abnormally proliferative developmental cells and mutagenic cells,MCM2 could be used to mark the status of the cells as a cellular proliferative marker,and then to be a diagnostic tool for some heterotypical pathological changes and tumors.Our study demonstrated that the expression and clinical significance of MCM2 in bladder transitional cell cancer(BTCC).Methods:The expression of MCM2 was examined by immunohistochemistry Streptavidin-Peroxidase method in 12 cases of normal bladder tissues and 42 cases of BTCC.Results:The positive expression of MCM2 in BTCC was 100%,whereas in normal tissues,no positive expression was found(P0.05).The expression of MCM2 was closely associated with tumor pathological grade(P